Nicotine
… the throat per unit of nicotine emitted by an ENDS.Conclusions Nicotine throat hit can be predicted and manipulated through ENDS device…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 99 of 876paclitaxeltrastuzumabpertuzumabcarboplatintamoxifenHerceptinTaxolPerjetabreast cancerBC+1 more
…ents and those treated with standard neoadjuvant HER2 therapies paclitaxel, with or without carboplatin, trastuzumab and pertuzumab (Taxol…
ML38517β-estradiolE2oestrogenPulmonary arterial hypertension (PAH)right ventricular (RV) failure
…aluate antioxidant, fibrotic, and mitochondrial markers.Results ML385 impaired mitochondrial function by increasing ROS, decreasing m…
mogamulizumabXL-11gastric cancerbreast cancerhematological malignancies
…TIL-Tregs, and reduce binding to peripheral Tregs compared with mogamulizumab. Anti-HER2×CCR4 DVD-Igs inhibit Treg chemotaxis to TME, and kil…
methylthioninium chloridesodium nitritemethaemoglobinaemiaWest Midlands Ambulance Service
…ium chloride under PGD indications. However, prehospital use of methylthioninium chloride for the treatment of methaemoglobinaemia currently lacks suffic…
phaco-iStentHydrus microstentphaco-HydrusFight Glaucoma Blindness registry
…ths (adjusted overall cohort, 41.2% vs 43.0% in phaco-Hydrus vs phaco-iStent respectively, p=0.81; matched cohort, 44.1% vs 43.2%, p=0.99). …
midazolam hydrochlorideclonidine hydrochlorideNumeta G16Efentanyl citratemidazolamclonidinefentanyl
…s) in situ.Background The case originated when a combination of midazolam hydrochloride, clonidine hydrochloride and fentanyl citrate with Numeta G16E …
gemcitabinecarboplatinALECSATmTNBCadvanced cancerNCT00891345Adoptive cell transfer-based immunotherapy
… consistent with the known toxicity profiles of carboplatin and gemcitabine. Notably, grade ≥3 AEs were predominantly hematological, with m…
sodium–glucose cotransporter 2 inhibitorsinsulinglucagon-like peptide-1 receptor agonistsmineralocorticoid receptor antagonistsPemafibrateACE inhibitorsglucagon-like peptide-1 receptor agonistangiotensin II receptor blockersstatinoral antihyperglycemic agents+4 more
…iated during follow-up—may still exist. At baseline, the use of sodium–glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and glucagon-like pept…
efartigimodefgartigimodIV efartigmodefgartigmodSC efartigmodIV efargartigmodefgartigmodMethodsNHNNResultsNHNNgeneralised MG (gMG)+1 more
…100 patients treated to date. Subcutaneous (SC) preparations of efartigimod have been available in the UK since March 2024Aim To describe t…
Rimegepantmigraine
…imegepant 75 mg) and 6.6% (placebo) of participants.Conclusions Rimegepant 75 mg demonstrated efficacy superior to placebo for acute treat…
CannabidiolclobazamvalproatephenytoinlamotrigineLennox Gastaut SyndromeNICE
…nts continued well beyond the 6 months reported here.Conclusion Cannabidiol demonstrates good efficacy and tolerability with high retention…